Lacking Backup Plan, WHO Allows Continued Use Of Contraceptives Barred From US
Executive Summary
Disappointed by firm's follow-up to FDA inspection that barred its US market access, WHO nevertheless lets contraceptives API maker with data integrity issues continue to supply rest-of-the-world markets with contraceptives of uncertain quality, in part for lack of a backup emergency contraceptives API supplier.
You may also be interested in...
‘Shadow’ Factory Challenges Continue For US FDA
Agency wants more information about API suppliers as it winds up case against KV Tech for hidden use of Dr. Reddy’s plant and seeks to find disappearing manufacturer of contaminated OTC eye drops.
US FDA, USP Raise Questions About Valisure’s Assertions Of Benzoyl Peroxide’s Benzene Risks
The US drug regulatory authority and standard-setting organization are evaluating the drug-screening venture’s findings regarding stability and potential carcinogenic risks associated with the widely used acne treatment, which includes Rx formulations.
US FDA Seeks More Power To Confront ‘Shadow’ Factory Challenges
Agency wants more information about API suppliers as it winds up case against KV Tech for hidden use of Dr. Reddy’s plant and seeks to find manufacturer of contaminated eye drops that disappeared.